Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 11, 2010

Premium

Mirna Therapeutics has appointed Yale University researcher Frank Slack as a scientific advisor.

Slack is currently an associate professor at Yale and focuses on the role of let-7 in cancer. He holds a PhD in molecular biology from Tufts University School of Medicine and a BSc from the University of Cape Town in South Africa.


Arrowhead Research, the parent company of Calando Pharmaceuticals, has named Ken Myszkowski as its CFO.

Myszkowski previously served as corporate controller for Broadwind Energy. Before that, he was controller for Epcor, a public energy company. He holds an MBA from the University of Chicago Booth School of Business.


Nektar Therapeutics has appointed Scott Greer to its board of directors.

Greer previously served as chairman of the board of Sirna Therapeutics, prior to its acquisition by Merck. Nektar's President and CEO Howard Robin was the former president and CEO of Sirna, and the company's COO Bharat Chowrira previously served as vice president at Sirna.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.